Articles les plus consultés

  • Les futures sur cac belle glissade < vix pas bon + 3%
        francis 13 Version sans publicité Marchés   Actualités   Analyses   Crypto   Fonds   Graphiques   Technique   Brokers   Outils   Portefe...
  • Nouvelles applications de médicaments avec des documents de soutien
    6% Hydroxyethyl Starch 130 / 0.4 in 0.9% Injection de chlorure de sodium (Voluven 500 mL freeflex flexible en plastique intraveineuse solut...
  • pre-market
    Top Gaining Stocks % Chg Dernier Symb Compagnie Le volume 16,22% 2.15 SRNE Sorrento Therapeut 7030 10,92% 2,64 CIE Cobalt Inte...
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Iridium   14.95 + 39.07% 0,60K Mondialisation de l'Inde.   0,4800 + 18,52% 1,80K...
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Oracle Corporation   51.30 + 10,73% 58.90K Staples Inc   9.25 + 6,81% 12,31K Delcat...
  • pre_market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Delcath   0.1230 + 24,24% 196,67K Neos Therapeutics I.   10.50 +16.67% 34.36K Enpha...
  • les élus
    Citoyens_Français ‏   @citoyenneFrance     8 juin Plus Attali : « Les élus n’ont plus de pouvoir et voici votre avenir » - Effr......
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Lipocine In   5.32 + 32,34% 38.64K Enphase Energy Inc   0,938 + 17,57% 10,37K Delca...
  • bonjour.. approbations
    28 juin 2017 Nom du médicament et  numéro de demande Ingrédient actif Formulaire de posologie / itinéraire Soumission Compagnie ...
  • $ pré-market
    Plus fortes hausses en préouverture Nom Dernier Var.% Vol. DragonWave Inc   1,3900 +25,23% 3,55K Alibaba   139,95 +11,35% 1,40M MoSys...

mardi 8 mai 2018

Tempus Announces New Initiative to Support Physicians Efforts to Deliver Personalized Medicine

Tempus Announces New Initiative to Support Physicians Efforts to Deliver Personalized Medicine
Posted by at Aucun commentaire:

CV Sciences, Inc. to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018

CV Sciences, Inc. to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018
Posted by at Aucun commentaire:

Abeona Therapeutics Announces Upcoming Presentations

Abeona Therapeutics Announces Upcoming Presentations: Presentations at the American Society of Gene and Cell Therapy Conference and the International Investigative Dermatology Conference
Posted by at Aucun commentaire:

Cyclacel Pharmaceuticals to Release First Quarter 2018 Financial Results

Cyclacel Pharmaceuticals to Release First Quarter 2018 Financial Results
Posted by at Aucun commentaire:

lundi 7 mai 2018

MediciNova Announces Plans to Collaborate with UCLA Researchers in Grant-Funded Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder and Withdrawal

MediciNova Announces Plans to Collaborate with UCLA Researchers in Grant-Funded Clinical Trial of MN-166 (ibudilast) in Alcohol Use Disorder and Withdrawal
Posted by at Aucun commentaire:

PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share

PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share
Posted by at Aucun commentaire:

Nymox Announces Relocation of Company Headquarters to Switzerland

Nymox Announces Relocation of Company Headquarters to Switzerland
Posted by at Aucun commentaire:
Inscription à : Articles (Atom)